Strategic and Operational Review Update
Filed with ASX · · 2 pages · English
Story so far
Earlier from IDT Australia
- Appointment interim Chief Executive Officer
- IDT Executes API Development Agreement
- CMAX transaction completed
- Appendix 4G
- Annual Report to shareholders
Later from IDT Australia
- Replacement Appendix 4D
- Divestment of Selected Generic Product Portfolio
- IDT receives FDA Warning Letter
- Update - Response to FDA Warning Letter
- Appointment of Chief Executive Officer
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia